Y

Serial Number 79382388
Registration 7628824
700

Registration Progress

Application Filed
Jun 19, 2023
Under Examination
Approved for Publication
Nov 12, 2024
Published for Opposition
Nov 12, 2024
Registered
Dec 31, 2024

Trademark Image

Y

Basic Information

Serial Number
79382388
Registration Number
7628824
Filing Date
June 19, 2023
Registration Date
December 31, 2024
Published for Opposition
November 12, 2024
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 31, 2024
Registration
Registered
Classes
005 042

Rights Holder

Y-mAbs Therapeutics, Inc

03
Address
230 Park Avenue, Suite 3350
New York NY 10169
US

Ownership History

Y-mAbs Therapeutics, Inc

Original Applicant
03
US

Y-mAbs Therapeutics, Inc

Owner at Publication
03
US

Y-mAbs Therapeutics, Inc

Original Registrant
03
US

Legal Representation

Attorney
/Andrew N. Spivak/

USPTO Deadlines

Next Deadline
1823 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20241231)
Due Date
December 31, 2030
Grace Period Ends
June 30, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Nov 20, 2025 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 18, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Oct 2, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 2, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jul 19, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Jun 26, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Jun 25, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 31, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 31, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Dec 31, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 12, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 12, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 23, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 3, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 11, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Jul 9, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 10, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 10, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 10, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 10, 2024 ATRV O ATTORNEY REVIEW COMPLETED Loading...
May 30, 2024 CREV I CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Loading...
May 6, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Apr 30, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 2, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 2, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 15, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 14, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 7, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 7, 2023 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 3, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 2, 2023 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer
Class 042
Research and development services in the field of antibodies; research and development services in the field of antibody technology; laboratory research and analysis in the field of the production of antibodies; scientific and technology services, namely, scientific research, testing and analysis in the field of antibodies and research and design services related thereto; industrial analysis services and industrial research services in the field of antibodies; industrial analysis and industrial research services in the field of chemistry

Additional Information

Design Mark
The mark consists of a stylized letter "Y" composed of two angled lines in dark green (hex-code: 055946) and lime green (hex-code: a0ce00) and two diagonal lines in dark blue (hex-code: 385a7e) in front of the incomplete outline of a circle in medium blue (hex-code: 6287ae). The color white represents background and is not claimed as a feature of the mark.
Color Claim
The color(s) dark green (hex-code: 055946), medium blue (hex-code: 6287ae), lime green (hex-code: a0ce00), and dark blue (hex-code: 385a7e) is/are claimed as a feature of the mark.
Pseudo Mark
Y MABS THERAPEUTICS

Classification

International Classes
005 042